Stromal cell-derived factor and granulocyte-monocyte colony-stimulating factor form a combined neovasculogenic therapy for ischemic cardiomyopathy.
Woo YJ, Grand TJ, Berry MF, Atluri P, Moise MA, Hsu VM, Cohen J, Fisher O, Burdick J, Taylor M, Zentko S, Liao G, Smith M, Kolakowski S, Jayasankar V, Gardner TJ, Sweeney HL.
Woo YJ, et al.
J Thorac Cardiovasc Surg. 2005 Aug;130(2):321-9. doi: 10.1016/j.jtcvs.2004.11.041.
J Thorac Cardiovasc Surg. 2005.
PMID: 16077394
Free article.